Scarica l'app Stockscreener
1.58
8.22%
0.12
Dopo l'orario di chiusura:
1.59
0.01
+0.63%
Precedente Chiudi:
$1.46
Aprire:
$1.46
Volume 24 ore:
74,656
Relative Volume:
1.01
Capitalizzazione di mercato:
$195.85M
Reddito:
$274.56M
Utile/perdita netta:
$-220.97M
Rapporto P/E:
-0.88
EPS:
-1.7954
Flusso di cassa netto:
$-13.85M
1 W Prestazione:
+0.64%
1M Prestazione:
-12.22%
6M Prestazione:
-12.71%
1 anno Prestazione:
-49.03%
Intervallo 1D:
$1.445
$1.60
Intervallo di 1 settimana:
$1.41
$1.61
Portata 52W:
$1.41
$3.505
Waldencast Plc Stock (WALD) Company Profile
Nome
Waldencast Plc
Settore
Industria
Telefono
(917) 546-6828
Indirizzo
10 BANK STREET, SUITE 560, WHITE PLAINS
Compare WALD vs PG, UL, CL, KVUE, KMB
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WALD
Waldencast Plc
|
1.58 | 195.85M | 274.56M | -220.97M | -13.85M | -1.7954 |
|
PG
Procter Gamble Co
|
150.65 | 350.11B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
64.05 | 139.95B | 56.67B | 6.96B | 7.39B | 3.1175 |
|
CL
Colgate Palmolive Co
|
88.84 | 71.21B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
KVUE
Kenvue Inc
|
17.49 | 33.52B | 15.12B | 1.47B | 1.72B | 0.764 |
|
KMB
Kimberly Clark Corp
|
98.84 | 32.81B | 17.23B | 1.75B | 1.64B | 6.0654 |
Waldencast Plc Stock (WALD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-14 | Ripresa | Jefferies | Buy |
| 2025-11-25 | Downgrade | Telsey Advisory Group | Outperform → Market Perform |
| 2025-04-22 | Iniziato | Alliance Global Partners | Buy |
| 2024-12-16 | Iniziato | TD Cowen | Hold |
| 2024-10-25 | Iniziato | Canaccord Genuity | Buy |
| 2024-05-01 | Reiterato | Telsey Advisory Group | Outperform |
| 2023-07-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
Mostra tutto
Waldencast Plc Borsa (WALD) Ultime notizie
Waldencast Acquisition earnings missed by $0.18, revenue fell short of estimates - Investing.com UK
Waldencast plc Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Waldencast Q4 2025 Earnings: Revenue Flat at $72M as Brand Transformation Takes Shape - technotrenz.com
Waldencast Q4 Financial Results Analysis - Intellectia AI
Waldencast Posts Flat 2025 Results as Obagi Surges, Launches Strategic Review and Deleveraging Drive - TipRanks
Waldencast Reports Q4 2025 and FY 2025 Financial Results - The Manila Times
Waldencast Reports Flat FY 2025 Revenue of $272.1 Million, Highlights Strategic Advancements in Beauty and Wellness Brands - Quiver Quantitative
Waldencast (NASDAQ: WALD) posts larger 2025 loss as EBITDA drops - Stock Titan
Big impairments and control risks at Waldencast (Nasdaq: WALD) in 2025 filing - Stock Titan
Quarterly Risk: Will Waldencast plc stock benefit from M A2026 Dividend Review & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date - Bitget
Price Action: Can Waldencast plc disrupt its industryJuly 2025 Review & Free High Return Stock Watch Alerts - baoquankhu1.vn
Quarterly Trades: Can Waldencast plc Equity Warrant navigate macro headwindsJuly 2025 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
WALD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
WALD Should I Buy - Intellectia AI
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ - The Globe and Mail
Schweiger clinics to trial new Obagi injectable in real-world ALOHA program - Stock Titan
New Highs: Is Waldencast plc Equity Warrant stock a value trapEarnings Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Guidance Update: Can Waldencast plc Equity Warrant outperform in the next rallyFed Meeting & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Obagi Medical and It's a Secret Med Spa announce collaboration in the Aloha program - marketscreener.com
Obagi Medical and It’s a Secret Med Spa Announce - GlobeNewswire
Luxury med spa chain to evaluate Obagi’s new ALOHA hyaluronic injectable - Stock Titan
Does Waldencast plc Equity Warrant have a sustainable dividendIPO Watch & Weekly Return Optimization Alerts - mfd.ru
Will Waldencast plc Equity Warrant face regulatory challengesMarket Sentiment Summary & Weekly Breakout Stock Alerts - mfd.ru
How The Waldencast (WALD) Narrative Is Shifting As Outlook Resets Meet Brand Optimism - Yahoo Finance
Earnings Report: Can Waldencast plc Equity Warrant navigate macro headwindsLong Setup & Real-Time Buy Zone Alerts - baoquankhu1.vn
Waldencast plc (WALD) Acquired Novaestiq Corp. and the US Rights to the Saypha Line of Hyaluronic Acid Injectable Gels - MSN
Waldencast outlines mid-teens revenue growth for 2025 backed by brand expansion - MSN
Downgrade Watch: Can Waldencast plc Equity Warrant outperform in the next rallyTrade Signal Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
Obagi Medical and Aesthetic Record Announce Collaboration - GlobeNewswire
Waldencast PLC (NASDAQ:WALD) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Is Waldencast plc stock positioned well for digital economy2025 Major Catalysts & Reliable Price Action Trade Plans - mfd.ru
Is Waldencast plc likely to announce a buybackQuarterly Market Summary & Free Verified High Yield Trade Plans - mfd.ru
Is Waldencast plc stock resilient to inflationMarket Growth Review & Real-Time Volume Analysis Alerts - mfd.ru
Is Waldencast plc Equity Warrant stock a value trapJuly 2025 Update & High Conviction Trade Alerts - mfd.ru
Why analysts remain bullish on Waldencast plc Equity Warrant stockJuly 2025 Earnings & Fast Gaining Stock Reports - mfd.ru
Is Waldencast plc Equity Warrant stock a top momentum play2025 Price Momentum & Weekly High Momentum Picks - mfd.ru
Waldencast: Strategic Reviews Are More Than Necessary (NASDAQ:WALD) - Seeking Alpha
Why Waldencast plc stock attracts high net worth investorsQuarterly Growth Report & Technical Entry and Exit Tips - mfd.ru
WALDWaldencast plc Latest Stock News & Market Updates - Stock Titan
Dividend Watch: What is the long term forecast for Waldencast plc stockMarket Risk Report & Community Shared Stock Ideas - baoquankhu1.vn
How The Story Behind Waldencast (WALD) Is Shifting In Analysts’ Eyes - Yahoo Finance UK
Obagi Medical names DermFx as partner for hyaluronic acid program - Investing.com South Africa
Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ - The Manila Times
SoCal med spa DermFx to evaluate Obagi MagIQ injectable in daily practice - Stock Titan
Retail Surge: Is Waldencast plc Equity Warrant a strong growth stockMarket Activity Recap & Verified Technical Trade Signals - baoquankhu1.vn
Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ - The Globe and Mail
Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ - The Manila Times
Obagi Medical and Moxie Announce Collaboration in the ALOHA - GlobeNewswire
Aug Technicals: Will Waldencast plc benefit from rising consumer demandMarket Risk Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect - Finviz
Waldencast Plc Azioni (WALD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):